137 related articles for article (PubMed ID: 28124868)
1. Presence and severity of lower urinary tract symptoms are inversely correlated with the risk of prostate cancer on prostate biopsy.
Cicione A; Cormio L; Cantiello F; Palumbo IM; DE Nunzio C; Lima E; Ucciero G; Carrieri G; Damiano R
Minerva Urol Nefrol; 2017 Oct; 69(5):486-492. PubMed ID: 28124868
[TBL] [Abstract][Full Text] [Related]
2. Is there any association between the severity of lower urinary tract symptoms and the risk of biopsy-detectable prostate cancer in patients with PSA level below 20 ng/ml in multi-core prostate biopsy?
Oh JJ; Jeong SJ; Jeong CW; Byun SS; Hong SK; Choe G; Lee SE
Prostate; 2013 Jan; 73(1):42-7. PubMed ID: 22585359
[TBL] [Abstract][Full Text] [Related]
3. Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/ml.
Chandra Engel J; Palsdottir T; Aly M; Egevad L; Grönberg H; Eklund M; Nordström T
Scand J Urol; 2020 Feb; 54(1):1-6. PubMed ID: 31876229
[No Abstract] [Full Text] [Related]
4. Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort.
Gayet M; Mannaerts CK; Nieboer D; Beerlage HP; Wijkstra H; Mulders PFA; Roobol MJ
Eur Urol Focus; 2018 Mar; 4(2):228-234. PubMed ID: 28753781
[TBL] [Abstract][Full Text] [Related]
5. Value of prostate gland volume measurement by transrectal US in prediction of the severity of lower urinary tract symptoms.
Tatar IG; Ergun O; Celtikci P; Birgi E; Hekimoglu B
Med Ultrason; 2014 Dec; 16(4):315-8. PubMed ID: 25463884
[TBL] [Abstract][Full Text] [Related]
6. Triptorelin relieves lower urinary tract symptoms in Chinese advanced prostate cancer patients: a multicenter, non-interventional, prospective study.
He LY; Zhang M; Chen ZW; Yuan JL; Ye DW; Ma LL; Wei H; Yang JG; Chen S; Wan B; Xia SJ; Weng ZL; Kong XB; Wei Q; Jin FS; Zhang XH; Qian WQ; Wang SS; Chen YH; Ma HS; Sun YH; Gao X
BMC Urol; 2018 Mar; 18(1):23. PubMed ID: 29587718
[TBL] [Abstract][Full Text] [Related]
7. Impact of Androgen Deprivation Therapy on Volume Reduction and Lower Urinary Tract Symptoms in Patients with Prostate Cancer.
Washino S; Hirai M; Saito K; Kobayashi Y; Arai Y; Miyagawa T
Low Urin Tract Symptoms; 2018 Jan; 10(1):57-63. PubMed ID: 27943566
[TBL] [Abstract][Full Text] [Related]
8. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
Tomlins SA; Day JR; Lonigro RJ; Hovelson DH; Siddiqui J; Kunju LP; Dunn RL; Meyer S; Hodge P; Groskopf J; Wei JT; Chinnaiyan AM
Eur Urol; 2016 Jul; 70(1):45-53. PubMed ID: 25985884
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
[TBL] [Abstract][Full Text] [Related]
10. The Single-parameter, Structure-based IsoPSA Assay Demonstrates Improved Diagnostic Accuracy for Detection of Any Prostate Cancer and High-grade Prostate Cancer Compared to a Concentration-based Assay of Total Prostate-specific Antigen: A Preliminary Report.
Klein EA; Chait A; Hafron JM; Kernen KM; Manickam K; Stephenson AJ; Wagner M; Zhu H; Kestranek A; Zaslavsky B; Stovsky M
Eur Urol; 2017 Dec; 72(6):942-949. PubMed ID: 28396176
[TBL] [Abstract][Full Text] [Related]
11. Serum prostate-specific antigen as a predictor of prostate volume and lower urinary tract symptoms in a community-based cohort: a large-scale Korean screening study.
Park DS; Oh JJ; Hong JY; Hong YK; Choi DK; Gong IH; Hwang JH; Kwon SW
Asian J Androl; 2013 Mar; 15(2):249-53. PubMed ID: 23353717
[TBL] [Abstract][Full Text] [Related]
12. Degarelix Versus Goserelin Plus Bicalutamide in the Short-Term Relief of Lower Urinary Tract Symptoms in Prostate Cancer Patients: Results of a Pooled Analysis.
Mason M; Richaud P; Bosnyak Z; Malmberg A; Neijber A
Low Urin Tract Symptoms; 2017 May; 9(2):82-88. PubMed ID: 28394498
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance is an independent predictor of severe lower urinary tract symptoms and of erectile dysfunction: results from a cross-sectional study.
Russo GI; Cimino S; Fragalà E; Privitera S; La Vignera S; Condorelli R; Calogero AE; Castelli T; Favilla V; Morgia G
J Sex Med; 2014 Aug; 11(8):2074-82. PubMed ID: 24836928
[TBL] [Abstract][Full Text] [Related]
14. Urinary tract symptoms and erectile function in patients at risk of prostate cancer.
Ramírez-Backhaus M; González-Tampán J; Ortiz-Rodríguez IM; Gómez-Ferrer Á; Rubio-Briones J; Collado-Serra A; Calatrava A; Rodríguez-Torreblanca C; Solsona-Narbón E
Actas Urol Esp; 2015; 39(6):360-6. PubMed ID: 25704504
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of the international prostate symptom score for positive prostate needle biopsy in the low-intermediate prostate-specific antigen range.
Kefi A; Irer B; Ozdemir I; Tuna B; Goktay Y; Yorukoğlu K; Esen A
Urol Int; 2005; 75(3):222-6. PubMed ID: 16215309
[TBL] [Abstract][Full Text] [Related]
16. A novel urinary long non-coding RNA transcript improves diagnostic accuracy in patients undergoing prostate biopsy.
Zhang W; Ren SC; Shi XL; Liu YW; Zhu YS; Jing TL; Wang FB; Chen R; Xu CL; Wang HQ; Wang HF; Wang Y; Liu B; Li YM; Fang ZY; Guo F; Lu X; Shen D; Gao X; Hou JG; Sun YH
Prostate; 2015 May; 75(6):653-61. PubMed ID: 25597901
[TBL] [Abstract][Full Text] [Related]
17. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
[TBL] [Abstract][Full Text] [Related]
18. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
[TBL] [Abstract][Full Text] [Related]
19. Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population.
Walz J; Suardi N; Hutterer GC; Perrotte P; Gallina A; Bénard F; Valiquette L; McCormack M; Graefen M; Montorsi F; Karakiewicz PI
J Endourol; 2008 Feb; 22(2):369-76. PubMed ID: 18294044
[TBL] [Abstract][Full Text] [Related]
20. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
